Sunteck Realty Limited (SUNTECK) Stock Analysis

Gujarat Themis Biosyn Limited Gujthem Q1 FY27 Results

GUJTHEM2 months ago

Gujarat Themis Biosyn Limited (gujthem) Q1 FY27: Topline Surges 22%, PAT Improves 22%

Gujarat Themis Biosyn Limited (GUJTHEM) reports a 22% year-on-year topline surge to Rs. 43.8 crores in Q1 FY27.

Gujarat Themis Biosyn Limited Gujthem Q2 FY27 Acquisitions

GUJTHEM3 months ago

Gujarat Themis Biosyn Limited Announces Strategic Acquisitions and Expansion Plans

Gujarat Themis Biosyn Limited (GUJTHEM) announces strategic acquisitions and expansion plans, including MicroBiopharm Japan and Sanofi’s product portfolio.

Gujarat Themis Biosyn Limited (gujthem) Q4 FY26 Results: Revenue Up 17%, Margin Expansion

GUJTHEM5 months ago

Gujarat Themis Biosyn Limited (gujthem) Q4 FY26: Strong Revenue Growth, Margin Expansion, and Strategic Acquisitions

Gujarat Themis Biosyn Limited (GUJTHEM) reports Q4 FY26 results with 17% revenue growth, margin expansion, and strategic acquisitions.

⚡	Breakout Alerts — Daily trendline breakout stocks
🤖	AI Scorecard — Instant score for any NSE/BSE stock
📊	Sector Analysis — Best performing industries daily
🎯	Auto Trendlines — Support & resistance on every chart
💰	Virtual Trading — Practice with ₹10L on real data

TradeAlone

Gujarat Themis Biosyn Limited (gujthem) Q1 FY27: Topline Surges 22%, PAT Improves 22%

Gujarat Themis Biosyn Limited Announces Strategic Acquisitions and Expansion Plans

Gujarat Themis Biosyn Limited (gujthem) Q4 FY26: Strong Revenue Growth, Margin Expansion, and Strategic Acquisitions

TradeAlone App